Replies to post #413109 on Anavex Life Sciences Corp (AVXL)

[abew4me]

Furthermore, I asked you to play Devil's advocate to prove Dr. Missling's claim that the P2b/3 AD trial had achieved their endpoints.

All you did was (basically) re-confirm your position as to how it didn't achieve them.

Can you try again?

Thanks

[Doc328]

Right Dec 2 was the day after the late breaking CTAD presentation when investors reacted to the presentation Dec 1. It was a volatile day but people spent most of it scratching their head trying to interpret the presentation and ding their own math. Dec 5 was the non-clarifying conference call that upset Wall Street as much as me. .

A sell off occurred November 28 after Missling presented the 4Q earnings call with nary a mention of the impending presentation. Since companies usually announce TLD days to weeks before an approaching conference (then going into more detail at the meeting), I always assumed that that move on moderate but not heavy volume was due to investors right-sizing their risk before CTAD. Implied Vol was crazy high that week.

Should put a calendar in front of me next time the week is discussed

[powerwalker]

abe, FYI from Yahoo! Finance, AVXL's trading from 11/25 to 12/6/22 with two big downs with one big up in between the downs:

Date Open High Low Close* Adj Close** Volume
Dec 06, 2022 9.21 9.21 8.34 8.38 8.38 6,006,800
Dec 05, 2022 12.03 12.11 9.56 9.58 9.58 8,403,500
Dec 02, 2022 12.57 13.23 10.66 12.05 12.05 45,682,600
Dec 01, 2022 8.90 9.57 8.80 8.87 8.87 2,157,500
Nov 30, 2022 8.96 9.14 8.29 8.82 8.82 4,017,300
Nov 29, 2022 9.24 9.46 8.77 8.94 8.94 2,155,400
Nov 28, 2022 12.46 12.49 8.86 9.10 9.10 4,344,800
Nov 25, 2022 11.30 11.95 11.25 11.89 11.89 778,700